1998
DOI: 10.1016/s0924-8579(98)00027-2
|View full text |Cite
|
Sign up to set email alerts
|

Study of β-lactam resistance in ceftazidime-resistant clinical isolates of Enterobacteriaceae

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
3
0

Year Published

2000
2000
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 25 publications
2
3
0
Order By: Relevance
“…For example the resistant rate to ciprofloxacin was (40.7%) this result was comparable to the result of Shamm et al( 2001) (20) found in a study that the resistant percentage of E. coli to ciprofloxacin was (39%). Resistance to pipracillin was (85.5%), this result was in agreement with that of Bujdakova et al(1998) (21) who found that (86%) of E. coli isolates resistant to pipracillin , and this may be due to the ability of E. coli to develop resistance to these antimicrobials through the production of β-lactamase enzyme which break the β-lactam ring of pipracillin. Resistance to nitrofurantoin was (2.6%), this result was in agreement with Akyar (2008) (22) who found that the resistant rate of E. coli against nitrofurantoin was (3%).Resistance to trimethoprim/ sulfamethoxazole (SXT) was (43.4%), this result may be attributed to the wide use of (SXT) as empirical therapy for urinary tract infection, however this result was in agreement with Gupta; Hooton and Stamm (2001) (23) who found that the resistance to (SXT) among E. coli isolates from patient with UTIs has increased, with a prevalence of resistance which is reported 30 to 50 percent .…”
Section: -Qualitative Methods (Disc Diffusion Test)supporting
confidence: 90%
“…For example the resistant rate to ciprofloxacin was (40.7%) this result was comparable to the result of Shamm et al( 2001) (20) found in a study that the resistant percentage of E. coli to ciprofloxacin was (39%). Resistance to pipracillin was (85.5%), this result was in agreement with that of Bujdakova et al(1998) (21) who found that (86%) of E. coli isolates resistant to pipracillin , and this may be due to the ability of E. coli to develop resistance to these antimicrobials through the production of β-lactamase enzyme which break the β-lactam ring of pipracillin. Resistance to nitrofurantoin was (2.6%), this result was in agreement with Akyar (2008) (22) who found that the resistant rate of E. coli against nitrofurantoin was (3%).Resistance to trimethoprim/ sulfamethoxazole (SXT) was (43.4%), this result may be attributed to the wide use of (SXT) as empirical therapy for urinary tract infection, however this result was in agreement with Gupta; Hooton and Stamm (2001) (23) who found that the resistance to (SXT) among E. coli isolates from patient with UTIs has increased, with a prevalence of resistance which is reported 30 to 50 percent .…”
Section: -Qualitative Methods (Disc Diffusion Test)supporting
confidence: 90%
“…All bacterial pathogens showed a variable resistance to beta (β) -lactam antibiotics such as, Ampicillin, Amoxicillin and Penicillin G. These agreements, with many earlier studies, reported a high degree of these drug resistances [41]. The Gram negative bacilli also were resistant to Cephalothin, Rifampicin and Erythromycin that reported the high prevalence of resistance to the commonly used antibiotics such as Ampicillin and Cephalothin [42]. Staphylococcus aureus was resistance to Ceftriaxone as (71.4%) and Cefotaxime as (57.1)%, these results are supported by the other work [43,44], Ciprofloxacin showed a strong activity against of all bacterial isolated and were very active against E.coli and Proteus mirabilis, however it has a less activity against Staphylococcus aureus , K. pneumonia and Pseudomonas aeruginosa.…”
Section: Discussionsupporting
confidence: 65%
“…Despite the fact that several antibiotics are available commercially for the treatment of both Gram-positive and Gram-negative bacteria, their extensive use has led in developing resistance in these pathogens; antibiotic resistance constitutes a significant challenge in global public health [3]. For instant, bacteria have reportedly acquired a novel form of β-lactamase enzyme that results in conferring resistance to antibiotics containing β-lactam ring such as cefotaxime [4][5][6]. Changing the structure of antibiotics' β-lactam moiety [7,8] and synthesizing new antibiotics with higher potencies [9] are two important strategies used for overcoming bacterial resistance.…”
Section: Introductionmentioning
confidence: 99%